156 related articles for article (PubMed ID: 11279543)
1. Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupus erythematosus.
Graninger WB; Steiner CW; Graninger MT; Aringer M; Smolen JS
Cell Death Differ; 2000 Oct; 7(10):966-72. PubMed ID: 11279543
[TBL] [Abstract][Full Text] [Related]
2. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
Chen DY; Hsieh TY; Hsieh CW; Lin FJ; Lan JL
Arthritis Rheum; 2007 Dec; 57(8):1530-8. PubMed ID: 18050226
[TBL] [Abstract][Full Text] [Related]
3. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
6. IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus.
Baranda L; de la Fuente H; Layseca-Espinosa E; Portales-Pérez D; Niño-Moreno P; Valencia-Pacheco G; Abud-Mendoza C; Alcocer-Varela J; González-Amaro R
Rheumatology (Oxford); 2005 Dec; 44(12):1507-13. PubMed ID: 16251219
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.
Seki M; Ushiyama C; Seta N; Abe K; Fukazawa T; Asakawa J; Takasaki Y; Hashimoto H
Arthritis Rheum; 1998 May; 41(5):823-30. PubMed ID: 9588733
[TBL] [Abstract][Full Text] [Related]
8. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
9. Effects of calcitonin gene-related peptide on apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Liu C; Chen X; Jin Y; Qu R; Jiang PF; Wen GM; Tang ZH
Clin Exp Dermatol; 2007 Nov; 32(6):650-3. PubMed ID: 17725664
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
[TBL] [Abstract][Full Text] [Related]
11. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
12. Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2.
Zaunders JJ; Moutouh-de Parseval L; Kitada S; Reed JC; Rought S; Genini D; Leoni L; Kelleher A; Cooper DA; Smith DE; Grey P; Estaquier J; Little S; Richman DD; Corbeil J
J Infect Dis; 2003 Jun; 187(11):1735-47. PubMed ID: 12751031
[TBL] [Abstract][Full Text] [Related]
13. Upregulated BclG(L) expression enhances apoptosis of peripheral blood CD4+ T lymphocytes in patients with systemic lupus erythematosus.
Luo N; Wu Y; Chen Y; Yang Z; Guo S; Fei L; Zhou D; Yang C; Wu S; Ni B; Hao F; Wu Y
Clin Immunol; 2009 Sep; 132(3):349-61. PubMed ID: 19524489
[TBL] [Abstract][Full Text] [Related]
14. Role of IL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus.
González-Amaro R; Portales-Pérez D; Baranda L; Abud-Mendoza C; Llorente L; Richaud-Patin Y; Alcocer-Varela J; Alarcón-Segovia D
J Autoimmun; 1998 Oct; 11(5):395-402. PubMed ID: 9802922
[TBL] [Abstract][Full Text] [Related]
15. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
[TBL] [Abstract][Full Text] [Related]
16. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.
Ohtsuka K; Gray JD; Stimmler MM; Toro B; Horwitz DA
J Immunol; 1998 Mar; 160(5):2539-45. PubMed ID: 9498800
[TBL] [Abstract][Full Text] [Related]
17. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family.
Di Renzo M; Rubegni P; Sbano P; Cuccia A; Castagnini C; Pompella G; Pasqui AL; Capecchi PL; Auteri A; Laghi Pasini F; Fimiani M
Arch Dermatol Res; 2003 Sep; 295(5):175-82. PubMed ID: 12883827
[TBL] [Abstract][Full Text] [Related]
18. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin-12 and its signaling molecules in peripheral blood mononuclear cells in systemic lupus erythematosus patients.
Li Z; Li Y; Huang L; Xu H; Yu X; Ye R
Chin Med J (Engl); 2002 Jun; 115(6):846-50. PubMed ID: 12123550
[TBL] [Abstract][Full Text] [Related]
20. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
J Rheumatol; 2007 Jul; 34(7):1580-4. PubMed ID: 17516614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
